SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Veru Inc. – ‘10-K’ for 9/30/20 – ‘XML’

On:  Thursday, 12/10/20, at 3:37pm ET   ·   For:  9/30/20   ·   Accession #:  863894-20-21   ·   File #:  1-13602

Previous ‘10-K’:  ‘10-K’ on 12/12/19 for 9/30/19   ·   Next:  ‘10-K’ on 12/2/21 for 9/30/21   ·   Latest:  ‘10-K/A’ on 4/1/24 for 9/30/23   ·   36 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

12/10/20  Veru Inc.                         10-K        9/30/20  100:9.9M

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.16M 
 2: EX-2.2      Plan of Acquisition, Reorganization, Arrangement,   HTML    300K 
                Liquidation or Succession                                        
 3: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     39K 
 4: EX-10.27    Material Contract                                   HTML     51K 
 5: EX-21       Subsidiaries List                                   HTML     27K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML     26K 
10: EX-99.1     Miscellaneous Exhibit                               HTML    104K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     29K 
17: R1          Document and Entity Information                     HTML     68K 
18: R2          Consolidated Balance Sheets                         HTML    117K 
19: R3          Consolidated Balance Sheets (Parenthetical)         HTML     40K 
20: R4          Consolidated Statements of Operations               HTML     71K 
21: R5          Consolidated Statements of Stockolders' Equity      HTML     67K 
22: R6          Consolidated Statements of Cash Flows               HTML    123K 
23: R7          Nature of Business and Significant Accounting       HTML     69K 
                Policies                                                         
24: R8          Liquidity                                           HTML     28K 
25: R9          Fair Value Measurements                             HTML     63K 
26: R10         Revenue from Contracts with Customers               HTML     57K 
27: R11         Accounts Receivable and Concentration of Credit     HTML     59K 
                Risk                                                             
28: R12         Inventory                                           HTML     50K 
29: R13         Property and Equipment                              HTML     52K 
30: R14         Intangible Assets and Goodwill                      HTML     89K 
31: R15         Debt                                                HTML     95K 
32: R16         Stockholders' Equity                                HTML     48K 
33: R17         Share-based Compensation                            HTML     98K 
34: R18         Leases                                              HTML    116K 
35: R19         Contingent Liabilities                              HTML     31K 
36: R20         Income Taxes                                        HTML    180K 
37: R21         Paycheck Protection Program                         HTML     28K 
38: R22         Net Loss Per Share                                  HTML     28K 
39: R23         Industry Segments                                   HTML     43K 
40: R24         Employee Benefit Plans                              HTML     30K 
41: R25         Related Party Transactions                          HTML     28K 
42: R26         Subsequent Events                                   HTML     30K 
43: R27         Basis of Presentation (Policy)                      HTML    123K 
44: R28         Fair Value Measurements (Tables)                    HTML     56K 
45: R29         Revenue from Contracts with Customers (Tables)      HTML     53K 
46: R30         Accounts Receivable and Concentration of Credit     HTML     55K 
                Risk (Tables)                                                    
47: R31         Inventory (Tables)                                  HTML     50K 
48: R32         Property and Equipment (Tables)                     HTML     50K 
49: R33         Intangible Assets and Goodwill (Tables)             HTML     85K 
50: R34         Debt (Tables)                                       HTML     86K 
51: R35         Share-based Compensation (Tables)                   HTML     92K 
52: R36         Leases (Tables)                                     HTML    104K 
53: R37         Income Taxes (Tables)                               HTML    172K 
54: R38         Industry Segments (Tables)                          HTML     40K 
55: R39         Basis of Presentation (Narrative) (Details)         HTML     67K 
56: R40         Fair Value Measurements (Narrative) (Details)       HTML     34K 
57: R41         Fair Value Measurements (Reconciliation of the      HTML     30K 
                Beginning and Ending Liability Balance) (Details)                
58: R42         Fair Value Measurements (Schedule of Qualitative    HTML     39K 
                Information) (Details)                                           
59: R43         Revenue from Contracts with Customers (Narrative)   HTML     32K 
                (Details)                                                        
60: R44         Revenue from Contracts with Customers (Revenue      HTML     36K 
                from Customers by Products) (Details)                            
61: R45         Revenue from Contracts with Customers (Revenue by   HTML     32K 
                Geographic Area) (Details)                                       
62: R46         Accounts Receivable and Concentration of Credit     HTML     44K 
                Risk (Narrative) (Details)                                       
63: R47         Accounts Receivable and Concentration of Credit     HTML     37K 
                Risk (Components of Accounts Receivable) (Details)               
64: R48         Accounts Receivable and Concentration of Credit     HTML     32K 
                Risk (Summary of Components of Allowance for                     
                Doubtful Accounts) (Details)                                     
65: R49         Inventory (Components Of Inventory) (Details)       HTML     43K 
66: R50         Property and Equipment (Narrative) (Details)        HTML     28K 
67: R51         Property and Equipment (Summary of Property and     HTML     50K 
                Equipment) (Details)                                             
68: R52         Intangible Assets and Goodwill (Narrative)          HTML     41K 
                (Details)                                                        
69: R53         Intangible Assets and Goodwill (Gross Carrying      HTML     46K 
                Amounts and Net Book Value of Intangible Assets)                 
                (Details)                                                        
70: R54         Intangible Assets and Goodwill (Estimated Future    HTML     41K 
                Amortization Expense) (Details)                                  
71: R55         Debt (Narrative) (Details)                          HTML     92K 
72: R56         Debt (Credit Agreement) (Details)                   HTML     54K 
73: R57         Debt (Residual Royalty Agreement Liability)         HTML     42K 
                (Details)                                                        
74: R58         Debt (Credit Agreement Interest Expense) (Details)  HTML     35K 
75: R59         Stockholders' Equity (Narrative) (Details)          HTML    128K 
76: R60         Share-based Compensation (Narrative) (Details)      HTML     95K 
77: R61         Share-based Compensation (Recorded Share-Based      HTML     35K 
                Compensation Expenses) (Details)                                 
78: R62         Share-based Compensation (Weighted Average          HTML     38K 
                Assumptions for Options Granted) (Details)                       
79: R63         Share-based Compensation (Summary of Stock Options  HTML     60K 
                Outstanding and Exercisable) (Details)                           
80: R64         Leases (Narrative) (Details)                        HTML     98K 
81: R65         Leases (Components of Lease Cost) (Details)         HTML     41K 
82: R66         Leases (Summary of Lease Information) (Details)     HTML     34K 
83: R67         Leases (Schedule of Maturities of Lease             HTML     65K 
                Liabilities) (Details)                                           
84: R68         Leases (Schedule of Future Minimum Payments Under   HTML     64K 
                Leases) (Details)                                                
85: R69         Contingent Liabilities (Narrative) (Details)        HTML     26K 
86: R70         Income Taxes (Narrative) (Details)                  HTML    104K 
87: R71         Income Taxes (Schedule of Income Before Income      HTML     30K 
                Taxes by Jurisdictions) (Details)                                
88: R72         Income Taxes (Reconciliation of Income Tax Expense  HTML     80K 
                (Benefit)) (Details)                                             
89: R73         Income Taxes (Summary of Federal And State Income   HTML     49K 
                Tax Provision (Benefit)) (Details)                               
90: R74         Income Taxes (Significant Components of Deferred    HTML     78K 
                Tax Assets and Liabilities) (Details)                            
91: R75         Income Taxes (Schedule of Deferred Tax Amounts      HTML     36K 
                Classified in Balance Sheets) (Details)                          
92: R76         Paycheck Protection Program (Narrative) (Details)   HTML     30K 
93: R77         Industry Segments (Narrative) (Details)             HTML     26K 
94: R78         Industry Segments (Schedule of Segment Reporting    HTML     35K 
                Information) (Details)                                           
95: R79         Employee Benefit Plans (Narrative) (Details)        HTML     35K 
96: R80         Related Party Transactions (Narrative) (Details)    HTML     33K 
97: R81         Subsequent Events (Narrative) (Details)             HTML     41K 
99: XML         IDEA XML File -- Filing Summary                      XML    180K 
98: EXCEL       IDEA Workbook of Financial Reports                  XLSX    128K 
11: EX-101.INS  XBRL Instance -- veru-20200930                       XML   2.22M 
13: EX-101.CAL  XBRL Calculations -- veru-20200930_cal               XML    286K 
14: EX-101.DEF  XBRL Definitions -- veru-20200930_def                XML    681K 
15: EX-101.LAB  XBRL Labels -- veru-20200930_lab                     XML   1.54M 
16: EX-101.PRE  XBRL Presentations -- veru-20200930_pre              XML   1.17M 
12: EX-101.SCH  XBRL Schema -- veru-20200930                         XSD    238K 
100: ZIP         XBRL Zipped Folder -- 0000863894-20-000021-xbrl      Zip    206K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.20.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 222 </ContextCount>
<ElementCount> 553 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 91 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 11 </UnitCount>
<MyReports>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00090 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00100 - Statement - CONSOLIDATED BALANCE SHEETS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementConsolidatedBalanceSheets </Role>
<ShortName> CONSOLIDATED BALANCE SHEETS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> CONSOLIDATED BALANCE SHEETS (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementConsolidatedStatementsOfOperations </Role>
<ShortName> CONSOLIDATED STATEMENTS OF OPERATIONS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00300 - Statement - CONSOLIDATED STATEMENTS OF STOCKOLDERS' EQUITY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementConsolidatedStatementsOfStockoldersEquity </Role>
<ShortName> CONSOLIDATED STATEMENTS OF STOCKOLDERS' EQUITY </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementConsolidatedStatementsOfCashFlows </Role>
<ShortName> CONSOLIDATED STATEMENTS OF CASH FLOWS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 10101 - Disclosure - Nature of Business and Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureNatureOfBusinessAndSignificantAccountingPolicies </Role>
<ShortName> Nature of Business and Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 10201 - Disclosure - Liquidity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLiquidity </Role>
<ShortName> Liquidity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 10301 - Disclosure - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurements </Role>
<ShortName> Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 10401 - Disclosure - Revenue from Contracts with Customers </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomers </Role>
<ShortName> Revenue from Contracts with Customers </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 10501 - Disclosure - Accounts Receivable and Concentration of Credit Risk </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRisk </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 10601 - Disclosure - Inventory </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureInventory </Role>
<ShortName> Inventory </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 10701 - Disclosure - Property and Equipment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePropertyAndEquipment </Role>
<ShortName> Property and Equipment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 10801 - Disclosure - Intangible Assets and Goodwill </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwill </Role>
<ShortName> Intangible Assets and Goodwill </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 10901 - Disclosure - Debt </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebt </Role>
<ShortName> Debt </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 11001 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureStockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 11101 - Disclosure - Share-based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensation </Role>
<ShortName> Share-based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 11201 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 11301 - Disclosure - Contingent Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureContingentLiabilities </Role>
<ShortName> Contingent Liabilities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 11401 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 11501 - Disclosure - Paycheck Protection Program </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePaycheckProtectionProgram </Role>
<ShortName> Paycheck Protection Program </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 11601 - Disclosure - Net Loss Per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureNetLossPerShare </Role>
<ShortName> Net Loss Per Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 11701 - Disclosure - Industry Segments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegments </Role>
<ShortName> Industry Segments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 11801 - Disclosure - Employee Benefit Plans </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureEmployeeBenefitPlans </Role>
<ShortName> Employee Benefit Plans </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 11901 - Disclosure - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRelatedPartyTransactions </Role>
<ShortName> Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 12001 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureSubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 20102 - Disclosure - Basis of Presentation (Policy) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBasisOfPresentationPolicy </Role>
<ShortName> Basis of Presentation (Policy) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureNatureOfBusinessAndSignificantAccountingPolicies </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 30303 - Disclosure - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurementsTables </Role>
<ShortName> Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureFairValueMeasurements </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 30403 - Disclosure - Revenue from Contracts with Customers (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </Role>
<ShortName> Revenue from Contracts with Customers (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomers </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 30503 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRisk </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 30603 - Disclosure - Inventory (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureInventoryTables </Role>
<ShortName> Inventory (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureInventory </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 30703 - Disclosure - Property and Equipment (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePropertyAndEquipmentTables </Role>
<ShortName> Property and Equipment (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosurePropertyAndEquipment </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 30803 - Disclosure - Intangible Assets and Goodwill (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables </Role>
<ShortName> Intangible Assets and Goodwill (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwill </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 30903 - Disclosure - Debt (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtTables </Role>
<ShortName> Debt (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebt </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 31103 - Disclosure - Share-based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationTables </Role>
<ShortName> Share-based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensation </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 31203 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeases </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 31403 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxes </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 31703 - Disclosure - Industry Segments (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegmentsTables </Role>
<ShortName> Industry Segments (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIndustrySegments </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 40101 - Disclosure - Basis of Presentation (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBasisOfPresentationNarrativeDetails </Role>
<ShortName> Basis of Presentation (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureBasisOfPresentationPolicy </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 40301 - Disclosure - Fair Value Measurements (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurementsNarrativeDetails </Role>
<ShortName> Fair Value Measurements (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 40302 - Disclosure - Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurementsReconciliationOfBeginningAndEndingLiabilityBalanceDetails </Role>
<ShortName> Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 40303 - Disclosure - Fair Value Measurements (Schedule of Qualitative Information) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurementsScheduleOfQualitativeInformationDetails </Role>
<ShortName> Fair Value Measurements (Schedule of Qualitative Information) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 40401 - Disclosure - Revenue from Contracts with Customers (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails </Role>
<ShortName> Revenue from Contracts with Customers (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </ParentRole>
<Position> 43 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 40402 - Disclosure - Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersRevenueFromCustomersByProductsDetails </Role>
<ShortName> Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 40403 - Disclosure - Revenue from Contracts with Customers (Revenue by Geographic Area) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersRevenueByGeographicAreaDetails </Role>
<ShortName> Revenue from Contracts with Customers (Revenue by Geographic Area) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </ParentRole>
<Position> 45 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 40501 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskNarrativeDetails </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables </ParentRole>
<Position> 46 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 40502 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Components of Accounts Receivable) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskComponentsOfAccountsReceivableDetails </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk (Components of Accounts Receivable) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables </ParentRole>
<Position> 47 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 40503 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Summary of Components of Allowance for Doubtful Accounts) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskSummaryOfComponentsOfAllowanceForDoubtfulAccountsDetails </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk (Summary of Components of Allowance for Doubtful Accounts) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables </ParentRole>
<Position> 48 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 40601 - Disclosure - Inventory (Components Of Inventory) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureInventoryComponentsOfInventoryDetails </Role>
<ShortName> Inventory (Components Of Inventory) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureInventoryTables </ParentRole>
<Position> 49 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 40701 - Disclosure - Property and Equipment (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePropertyAndEquipmentNarrativeDetails </Role>
<ShortName> Property and Equipment (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosurePropertyAndEquipmentTables </ParentRole>
<Position> 50 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 40702 - Disclosure - Property and Equipment (Summary of Property and Equipment) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails </Role>
<ShortName> Property and Equipment (Summary of Property and Equipment) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosurePropertyAndEquipmentTables </ParentRole>
<Position> 51 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 40801 - Disclosure - Intangible Assets and Goodwill (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillNarrativeDetails </Role>
<ShortName> Intangible Assets and Goodwill (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables </ParentRole>
<Position> 52 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 40804 - Disclosure - Intangible Assets and Goodwill (Gross Carrying Amounts and Net Book Value of Intangible Assets) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillGrossCarryingAmountsAndNetBookValueOfIntangibleAssetsDetails </Role>
<ShortName> Intangible Assets and Goodwill (Gross Carrying Amounts and Net Book Value of Intangible Assets) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables </ParentRole>
<Position> 53 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 40805 - Disclosure - Intangible Assets and Goodwill (Estimated Future Amortization Expense) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillEstimatedFutureAmortizationExpenseDetails </Role>
<ShortName> Intangible Assets and Goodwill (Estimated Future Amortization Expense) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables </ParentRole>
<Position> 54 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 40901 - Disclosure - Debt (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtNarrativeDetails </Role>
<ShortName> Debt (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 55 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 40902 - Disclosure - Debt (Credit Agreement) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtCreditAgreementDetails </Role>
<ShortName> Debt (Credit Agreement) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 56 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 40903 - Disclosure - Debt (Residual Royalty Agreement Liability) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtResidualRoyaltyAgreementLiabilityDetails </Role>
<ShortName> Debt (Residual Royalty Agreement Liability) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 57 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 40904 - Disclosure - Debt (Credit Agreement Interest Expense) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtCreditAgreementInterestExpenseDetails </Role>
<ShortName> Debt (Credit Agreement Interest Expense) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 58 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 41001 - Disclosure - Stockholders' Equity (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureStockholdersEquityNarrativeDetails </Role>
<ShortName> Stockholders' Equity (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureStockholdersEquity </ParentRole>
<Position> 59 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 41101 - Disclosure - Share-based Compensation (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationNarrativeDetails </Role>
<ShortName> Share-based Compensation (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 60 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 41102 - Disclosure - Share-based Compensation (Recorded Share-Based Compensation Expenses) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationRecordedShareBasedCompensationExpensesDetails </Role>
<ShortName> Share-based Compensation (Recorded Share-Based Compensation Expenses) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 61 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 41103 - Disclosure - Share-based Compensation (Weighted Average Assumptions for Options Granted) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsForOptionsGrantedDetails </Role>
<ShortName> Share-based Compensation (Weighted Average Assumptions for Options Granted) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 62 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 41104 - Disclosure - Share-based Compensation (Summary of Stock Options Outstanding and Exercisable) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationSummaryOfStockOptionsOutstandingAndExercisableDetails </Role>
<ShortName> Share-based Compensation (Summary of Stock Options Outstanding and Exercisable) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 63 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 41201 - Disclosure - Leases (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesNarrativeDetails </Role>
<ShortName> Leases (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 64 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 41202 - Disclosure - Leases (Components of Lease Cost) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesComponentsOfLeaseCostDetails </Role>
<ShortName> Leases (Components of Lease Cost) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 65 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R66.htm </HtmlFileName>
<LongName> 41203 - Disclosure - Leases (Summary of Lease Information) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesSummaryOfLeaseInformationDetails </Role>
<ShortName> Leases (Summary of Lease Information) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 66 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R67.htm </HtmlFileName>
<LongName> 41204 - Disclosure - Leases (Schedule of Maturities of Lease Liabilities) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails </Role>
<ShortName> Leases (Schedule of Maturities of Lease Liabilities) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 67 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R68.htm </HtmlFileName>
<LongName> 41205 - Disclosure - Leases (Schedule of Future Minimum Payments Under Leases) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesScheduleOfFutureMinimumPaymentsUnderLeasesDetails </Role>
<ShortName> Leases (Schedule of Future Minimum Payments Under Leases) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 68 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R69.htm </HtmlFileName>
<LongName> 41301 - Disclosure - Contingent Liabilities (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureContingentLiabilitiesNarrativeDetails </Role>
<ShortName> Contingent Liabilities (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureContingentLiabilities </ParentRole>
<Position> 69 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R70.htm </HtmlFileName>
<LongName> 41401 - Disclosure - Income Taxes (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesNarrativeDetails </Role>
<ShortName> Income Taxes (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 70 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R71.htm </HtmlFileName>
<LongName> 41402 - Disclosure - Income Taxes (Schedule of Income Before Income Taxes by Jurisdictions) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesScheduleOfIncomeBeforeIncomeTaxesByJurisdictionsDetails </Role>
<ShortName> Income Taxes (Schedule of Income Before Income Taxes by Jurisdictions) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 71 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R72.htm </HtmlFileName>
<LongName> 41403 - Disclosure - Income Taxes (Reconciliation of Income Tax Expense (Benefit)) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpenseBenefitDetails </Role>
<ShortName> Income Taxes (Reconciliation of Income Tax Expense (Benefit)) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 72 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R73.htm </HtmlFileName>
<LongName> 41404 - Disclosure - Income Taxes (Summary of Federal And State Income Tax Provision (Benefit)) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesSummaryOfFederalAndStateIncomeTaxProvisionBenefitDetails </Role>
<ShortName> Income Taxes (Summary of Federal And State Income Tax Provision (Benefit)) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 73 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R74.htm </HtmlFileName>
<LongName> 41405 - Disclosure - Income Taxes (Significant Components of Deferred Tax Assets and Liabilities) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails </Role>
<ShortName> Income Taxes (Significant Components of Deferred Tax Assets and Liabilities) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 74 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R75.htm </HtmlFileName>
<LongName> 41406 - Disclosure - Income Taxes (Schedule of Deferred Tax Amounts Classified in Balance Sheets) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAmountsClassifiedInBalanceSheetsDetails </Role>
<ShortName> Income Taxes (Schedule of Deferred Tax Amounts Classified in Balance Sheets) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 75 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R76.htm </HtmlFileName>
<LongName> 41501 - Disclosure - Paycheck Protection Program (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePaycheckProtectionProgramNarrativeDetails </Role>
<ShortName> Paycheck Protection Program (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosurePaycheckProtectionProgram </ParentRole>
<Position> 76 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R77.htm </HtmlFileName>
<LongName> 41701 - Disclosure - Industry Segments (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegmentsNarrativeDetails </Role>
<ShortName> Industry Segments (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIndustrySegmentsTables </ParentRole>
<Position> 77 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R78.htm </HtmlFileName>
<LongName> 41702 - Disclosure - Industry Segments (Schedule of Segment Reporting Information) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegmentsScheduleOfSegmentReportingInformationDetails </Role>
<ShortName> Industry Segments (Schedule of Segment Reporting Information) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIndustrySegmentsTables </ParentRole>
<Position> 78 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R79.htm </HtmlFileName>
<LongName> 41801 - Disclosure - Employee Benefit Plans (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureEmployeeBenefitPlansNarrativeDetails </Role>
<ShortName> Employee Benefit Plans (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureEmployeeBenefitPlans </ParentRole>
<Position> 79 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R80.htm </HtmlFileName>
<LongName> 41901 - Disclosure - Related Party Transactions (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRelatedPartyTransactionsNarrativeDetails </Role>
<ShortName> Related Party Transactions (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRelatedPartyTransactions </ParentRole>
<Position> 80 </Position>
</Report>
<Report instance="veru-20200930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R81.htm </HtmlFileName>
<LongName> 42001 - Disclosure - Subsequent Events (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureSubsequentEventsNarrativeDetails </Role>
<ShortName> Subsequent Events (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureSubsequentEvents </ParentRole>
<Position> 81 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> veru-20200930.xml </File>
<File> veru-20200930.xsd </File>
<File> veru-20200930_cal.xml </File>
<File> veru-20200930_def.xml </File>
<File> veru-20200930_lab.xml </File>
<File> veru-20200930_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/us-gaap/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/country/2017-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

12 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/24  Veru Inc.                         10-K/A      9/30/23   96:18M
12/08/23  Veru Inc.                         10-K        9/30/23   88:14M
12/05/22  Veru Inc.                         10-K        9/30/22   87:13M
 8/11/22  Veru Inc.                         10-Q        6/30/22   79:12M
 5/12/22  Veru Inc.                         10-Q        3/31/22   78:11M
 2/09/22  Veru Inc.                         10-Q       12/31/21   81:6.2M
12/02/21  Veru Inc.                         10-K        9/30/21   96:9.5M
 8/12/21  Veru Inc.                         10-Q        6/30/21   82:12M
 5/12/21  Veru Inc.                         10-Q        3/31/21   81:7.3M
 2/18/21  Veru Inc.                         424B5                  1:459K                                   Donnelley … Solutions/FA
 2/17/21  Veru Inc.                         424B5                  1:458K                                   Donnelley … Solutions/FA
 2/10/21  Veru Inc.                         10-Q       12/31/20   81:6.1M

24 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/26/20  Veru Inc.                         8-K:1,9     6/26/20    4:267K                                   Donnelley … Solutions/FA
 5/13/20  Veru Inc.                         10-Q        3/31/20   84:7.3M
 3/26/20  Veru Inc.                         8-K:5,9     3/24/20    2:499K
 5/15/19  Veru Inc.                         10-Q        3/31/19   72:6.7M
 3/29/19  Veru Inc.                         8-K:5,9     3/26/19    3:161K                                   Donnelley … Solutions/FA
12/13/18  Veru Inc.                         10-K        9/30/18   91:8.9M
 9/27/18  Veru Inc.                         8-K:1,8,9   9/27/18    6:358K                                   Donnelley … Solutions/FA
 8/14/18  Veru Inc.                         10-Q        6/30/18   74:6.8M
 5/04/18  Veru Inc.                         8-K:5,9     5/02/18    2:168K                                   Donnelley … Solutions/FA
 3/26/18  Veru Inc.                         8-K:5,9     3/20/18    4:273K                                   Donnelley … Solutions/FA
 3/06/18  Veru Inc.                         8-K:1,2,9   3/05/18    6:758K                                   Donnelley … Solutions/FA
 8/01/17  Veru Inc.                         8-K:3,5,9   7/28/17    3:190K                                   Donnelley … Solutions/FA
 2/09/17  Veru Inc.                         10-Q       12/31/16   66:5.4M
12/12/16  Veru Inc.                         10-K        9/30/16   85:9.6M
11/02/16  Veru Inc.                         8-K:1,2,3,510/31/16    7:824K                                   Donnelley … Solutions/FA
 4/06/16  Veru Inc.                         8-K:1,3,5,9 4/05/16    5:909K                                   Donnelley … Solutions/FA
12/03/13  Veru Inc.                         10-K        9/30/13   78:9.6M                                   Globenewswire Inc./FA
12/17/09  Veru Inc.                         10-K        9/30/09    8:1.5M                                   Reinhart Boerner … SC/FA
 3/31/08  Veru Inc.                         8-K:5,9     3/27/08    2:132K                                   Reinhart Boerner … SC/FA
 5/17/04  Veru Inc.                         10QSB       3/31/04    5:289K                                   Reinhart Boerner … SC/FA
 5/15/03  Veru Inc.                         10QSB       3/31/03    2:79K                                    Reinhart Boerner … SC/FA
 9/06/02  Veru Inc.                         SB-2                   4:270K                                   Reinhart Boerner … SC/FA
 9/21/00  Veru Inc.                         SB-2                   5:302K                                   Reinhart Boerner … SC/FA
10/19/99  Veru Inc.                         SB-2                   5:381K                                   Bowne - Bde
↑Top
Filing Submission 0000863894-20-000021   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 1:51:12.3pm ET